Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Intranasal Ketamine With Dexmedetomidine for the Treatment of Children With Autism Spectrum Disorder

To see complete record on, please visit this link

Id: NCT03434366

Organisation Name: Guangzhou Women and Children's Medical Center

Overal Status: Suspended

Start Date: January 20, 2018

Last Update: April 12, 2022

Lead Sponsor: Guangzhou Women and Children's Medical Center

Brief Summary: Autism spectrum disorder (ASD) is a life-long neurodevelopmental disorder characterized by qualitative abnormalities in reciprocal social interactions and patterns of communication, and by a restricted, stereotyped, repetitive repertoire of interests and activities. The use of medications in adolescents and young adults with ASD is extremely common. However, few data address the effectiveness and harms of medications specifically in this population.

The purpose of the study is to determine the efficacy and safety of intranasal ketamine with dexmedetomidine in children with ASD.

  • Autism Spectrum Disorder

Total execution time in seconds: 0.20139312744141